Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4 triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents

被引:77
作者
Banerjee, Anupam G. [1 ]
Das, Nirupam [1 ]
Shengule, Sushant A. [2 ]
Srivastava, Radhey Shyam [1 ]
Shrivastava, Sushant Kumar [1 ]
机构
[1] Banaras Hindu Univ, Dept Pharmaceut, Indian Inst Technol, Pharmaceut Chem Res Lab, Varanasi 221005, Uttar Pradesh, India
[2] Natl Toxicol Ctr, Pune 411041, Maharashtra, India
关键词
1,2,4-triazine; 1,3,4-oxadiazole; Anti-inflammatory; Analgesic; Cyclooxygenase; DRUG DISCOVERY; DENATURATION; INHIBITION; MODEL; ARTHRITIS; EXTRACT; ALBUMIN; NSAIDS; SERUM; PAIN;
D O I
10.1016/j.ejmech.2015.06.020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of triazin-3(2H)-one derivatives bearing 1,3,4 oxadiazole (4a-4o) were synthesized, characterized and evaluated for anti inflammatory and analgesic activities. Preliminary in vitro anti inflammatory activity was assessed using an albumin denaturation assay. The promising compounds were further evaluated in acute, sub chronic and chronic animal models of inflammation. Derivatives 4d, 4e, 4g, 4j and 41 exhibited significant anti inflammatory activity with reduced ulcerogenic, hepatotoxic and renotoxic liabilities compared to standard indomethacin. These potential derivatives were also evaluated for in vivo analgesic activity using a writhing model and the formalin-induced paw licking response in mice. Compounds 4d, 4e and 4g exhibited comparable analgesic activity, whereas 4j and 41 yielded moderate effects. The specificity of compounds 4d, 4e, 4g, 4j, and 41 to inhibit (cyclooxygenase 1) COX-1 and (cyclooxygenase-2) COX-2 isozymes and their kinetics were also determined via an in vitro COX inhibition assay. In silico docking studies were performed using a molecular dynamics simulation of the most active compound 4d (COX-2 IC50: 3.07 mu M) at the COX-2 active site. The outcome of this exercise helped to verify the consensual interaction of these compounds with the enzyme. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:81 / 95
页数:15
相关论文
共 51 条
  • [41] Spector W G, 1969, Int Rev Exp Pathol, V8, P1
  • [42] SWINGLE KF, 1972, J PHARMACOL EXP THER, V183, P226
  • [43] DISTENTION ULCER AS A MODEL FOR TESTING OF DRUGS FOR ULCEROGENIC SIDE-EFFECTS
    SZELENYI, I
    THIEMER, K
    [J]. ARCHIVES OF TOXICOLOGY, 1978, 41 (01) : 99 - 105
  • [44] Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives
    Sztanke, Krzysztof
    Pastemak, Kazimierz
    Rzymowska, Jolanta
    Sztanke, Malgorzata
    Kandefer-Szerszen, Martyna
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (05) : 1085 - 1094
  • [45] THE FORMALIN TEST - AN EVALUATION OF THE METHOD
    TJOLSEN, A
    BERGE, OG
    HUNSKAAR, S
    ROSLAND, JH
    HOLE, K
    [J]. PAIN, 1992, 51 (01) : 5 - 17
  • [46] Umapathy E, 2010, J MED PLANTS RES, V4, P789
  • [47] VARLEY H, 1988, PRACTICAL CLIN BIOCH, P236
  • [48] VINEGAR R, 1969, J PHARMACOL EXP THER, V166, P96
  • [49] Williams LAD, 2008, W INDIAN MED J, V57, P327
  • [50] PROSTAGLANDIN-E2, PROSTAGLANDIN-I2 AND THE VASCULAR CHANGES OF INFLAMMATION
    WILLIAMS, TJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1979, 65 (03) : 517 - 524